Published in Autoimmune Dis on October 04, 2012
Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes. Transl Res (2015) 0.86
Expression analysis of immune related genes identified from the coelomocytes of sea cucumber (Apostichopus japonicus) in response to LPS challenge. Int J Mol Sci (2014) 0.78
Deletion of CD24 impairs development of heat shock protein gp96-driven autoimmune disease through expansion of myeloid-derived suppressor cells. J Immunol (2014) 0.78
HSP27 and 70 expression in thymic epithelial tumors and benign thymic alterations: diagnostic, prognostic and physiologic implications. Sci Rep (2016) 0.77
HDAC expression and activity is upregulated in diseased lupus-prone mice. Int Immunopharmacol (2015) 0.76
Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment. Springerplus (2016) 0.75
Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies. Cell Stress Chaperones (2016) 0.75
Heat Shock Protein 90α Is a Potential Serological Biomarker of Acute Rejection after Renal Transplantation. PLoS One (2016) 0.75
The heat-shock response. Annu Rev Biochem (1986) 20.16
The unfolded protein response: from stress pathway to homeostatic regulation. Science (2011) 15.71
Molecular chaperones in the cytosol: from nascent chain to folded protein. Science (2002) 15.09
Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev (1998) 8.13
Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell (2000) 5.56
ER stress and diseases. FEBS J (2007) 5.03
Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol (2010) 4.63
GHKL, an emergent ATPase/kinase superfamily. Trends Biochem Sci (2000) 4.20
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) (2003) 4.00
Chaperone-mediated protein folding. Physiol Rev (1999) 3.73
The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther (1998) 3.66
Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol (2002) 3.55
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med (2005) 3.43
Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science (1997) 2.92
The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol (2004) 2.67
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med (2006) 2.53
Heat shock proteins as regulators of the immune response. Lancet (2003) 2.42
Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett (2004) 2.26
Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem (2000) 1.68
Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med (2012) 1.63
Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones (1999) 1.62
Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci U S A (2003) 1.54
Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann N Y Acad Sci (2007) 1.50
Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep (2009) 1.49
Mechanism and components of endoplasmic reticulum-associated degradation. J Biochem (2009) 1.48
Stress-induced release of HSC70 from human tumors. Cell Immunol (2003) 1.36
Protein folding and quality control in the ER. Cold Spring Harb Perspect Biol (2011) 1.33
Heat shock protein and innate immunity. Cell Mol Immunol (2004) 1.33
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response. Lupus (1999) 1.31
Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum (2008) 1.27
Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation. Expert Rev Vaccines (2008) 1.19
Heat shock proteins in immunity. Handb Exp Pharmacol (2006) 1.16
Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One (2009) 1.14
The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation. J Biol Chem (2001) 1.13
Immune response against heat shock proteins in infectious diseases. Immunobiology (1999) 1.12
Circulating heat shock protein 70 in health, aging and disease. BMC Immunol (2011) 1.11
The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurochem (2006) 1.04
HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression. Cell Stress Chaperones (2007) 1.03
Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe? Cell Stress Chaperones (2006) 1.01
Identification of gp96 as a novel target for treatment of autoimmune disease in mice. PLoS One (2010) 1.00
Heat shock proteins induce T cell regulation of chronic inflammation. Ann Rheum Dis (2006) 0.98
Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol (2004) 0.98
Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus. Cell Mol Immunol (2012) 0.95
Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90. J Autoimmun (2001) 0.94
Heat shock proteins in multiple sclerosis and other autoimmune diseases. Immunol Today (1993) 0.93
Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies. Clin Exp Immunol (2002) 0.92
Transcriptional modulation of heat-shock protein gene expression. Biochem Res Int (2010) 0.91
Immunomodulatory activity of extracellular heat shock proteins and their autoantibodies. Microbiol Immunol (2010) 0.88
Crossreactivity of SLE autoantibodies with 70 kDa heat shock proteins of Mycobacterium tuberculosis. Microbiol Immunol (2001) 0.86
Molecular chaperones and the heat shock response at Cold Spring Harbor. Cell Stress Chaperones (1997) 0.81
Antibodies to 65 kDa and 70 kDa heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol (1992) 0.81
Antibodies to human recombinant lipocortin-I in inflammatory bowel disease. Clin Sci (Lond) (1993) 0.80
Anti-HSP90 autoantibodies in sera of infertile women identify a dominant, conserved epitope EP6 (380-389) of HSP90 beta protein. Reprod Biol Endocrinol (2011) 0.79
LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med (2003) 5.97
Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A (2006) 3.31
Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci U S A (2003) 2.91
Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol (2004) 2.67
Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol (2003) 2.61
ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A (2008) 2.48
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem (2005) 2.47
On the role of IRF in host defense. J Interferon Cytokine Res (2002) 2.44
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem (2004) 2.26
Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol (2002) 2.03
Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res (2003) 1.79
Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem (2005) 1.79
HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology (2007) 1.40
Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J Biol Chem (2008) 1.31
Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev (2007) 1.29
Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. J Virol (2010) 1.27
Antiviral activity of innate immune protein ISG15. J Innate Immun (2009) 1.25
Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol Cell Biol (2008) 1.22
Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J Immunol (2012) 1.22
Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A (2010) 1.19
Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem (2003) 1.12
Stimulation of IRF-7 gene expression by tumor necrosis factor alpha: requirement for NFkappa B transcription factor and gene accessibility. J Biol Chem (2002) 1.02
The innate antiviral response: new insights into a continuing story. Adv Virus Res (2007) 1.00
Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus. J Biol Chem (2007) 0.98
Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog (2011) 0.96
Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors. J Virol (2002) 0.95
Interferon targeted genes in host defense. Autoimmunity (2003) 0.92
Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability. J Biol Chem (2012) 0.91
Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway. J Virol (2011) 0.89
IKKalpha negatively regulates IRF-5 function in a MyD88-TRAF6 pathway. Cell Signal (2009) 0.83
Distinct roles of Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer. J Virol (2013) 0.83
Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain. PLoS One (2012) 0.82
Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. J Immunol (2011) 0.82
p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3. Mol Cell Biol (2013) 0.81
Interferon research: a brief history. Methods Mol Med (2005) 0.81